Tejas Savant

Stock Analyst at Morgan Stanley

(0)
# 4146
Out of 5,240 analysts
280
Total ratings
34.92%
Success rate
-6.88%
Average return
39 Stocks
Name Action Price Target Current % Upside Ratings Updated
Thermo Fisher Scient...
Maintains: Overweight
670 647
557.25 16.11% 13 Jan 13, 2025
Illumina
Maintains: Equal-Weight
156 150
136.28 10.07% 6 Jan 13, 2025
Hologic
Maintains: Equal-Weight
84 82
70.16 16.88% 8 Jan 13, 2025
10x Genomics
Maintains: Overweight
30 28
15.42 81.58% 12 Jan 13, 2025
Stevanato Group
Assumes: Equal-Weight
24 23
21.57 6.63% 1 Dec 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Equal-Weight
16
18.09 -11.55% 1 Nov 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
26 28
40.98 -31.67% 12 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
32 21
13.68 53.51% 2 Nov 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
132 176
165.72 6.2% 12 Nov 14, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
280 265
198.04 33.81% 10 Nov 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
11 10
4.54 120.26% 12 Aug 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
4 2
1.84 8.7% 11 Aug 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
4 3
2.66 12.78% 10 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
28 29
21.71 33.58% 15 Jul 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
44
31.84 38.19% 1 Jul 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
80 40
8.54 368.38% 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
26 26
n/a n/a 12 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
8 7
7.25 -3.45% 8 Nov 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
16 17
13.87 22.57% 12 Nov 8, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
14 8
n/a n/a 11 Oct 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
13 10
6.04 65.56% 11 Oct 24, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
52 55
n/a n/a 11 Aug 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Equal-Weight
1
n/a n/a 1 Aug 18, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Equal-Weight
16
7.48 113.9% 1 Aug 17, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
6 6
1.86 222.58% 3 Aug 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
11 10
3.38 195.86% 8 May 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Equal-Weight
3
1.08 154.63% 6 Mar 7, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
11 5
5.12 -2.34% 12 Feb 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
11 10
2.3 334.78% 10 Feb 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
80 73
37.25 95.97% 9 Feb 21, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
5 2
n/a n/a 5 Jan 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
10 8
n/a n/a 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underweight
10 5
n/a n/a 8 Aug 10, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
350 250
178.35 40.17% 1 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
7 5
1.15 334.78% 5 May 12, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
17 19
n/a n/a 3 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
18 17
n/a n/a 8 May 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
21 20
n/a n/a 2 Mar 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
35 65
n/a n/a 1 Feb 22, 2021